Estimating epidemiologic dynamics from cross-sectional viral load distributions.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
16 07 2021
Historique:
received: 13 02 2021
accepted: 28 05 2021
pubmed: 5 6 2021
medline: 9 9 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Estimating an epidemic's trajectory is crucial for developing public health responses to infectious diseases, but case data used for such estimation are confounded by variable testing practices. We show that the population distribution of viral loads observed under random or symptom-based surveillance-in the form of cycle threshold (Ct) values obtained from reverse transcription quantitative polymerase chain reaction testing-changes during an epidemic. Thus, Ct values from even limited numbers of random samples can provide improved estimates of an epidemic's trajectory. Combining data from multiple such samples improves the precision and robustness of this estimation. We apply our methods to Ct values from surveillance conducted during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in a variety of settings and offer alternative approaches for real-time estimates of epidemic trajectories for outbreak management and response.

Identifiants

pubmed: 34083451
pii: science.abh0635
doi: 10.1126/science.abh0635
pmc: PMC8527857
mid: NIHMS1741625
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : ACL HHS
ID : U01IP001121
Pays : United States
Organisme : NIH HHS
ID : DP5 OD028145
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001121
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA261277
Pays : United States

Commentaires et corrections

Type : UpdateOf
Type : CommentIn

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
Clin Infect Dis. 2020 Nov 19;71(16):2249-2251
pubmed: 32306036
Phys Chem Chem Phys. 2005 Dec 7;7(23):3910-6
pubmed: 19810318
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Infect Dis. 2021 May 28;223(10):1666-1670
pubmed: 33580259
Stat Med. 2012 Sep 10;31(20):2240-8
pubmed: 22419564
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
BMJ. 2020 Dec 23;371:m4944
pubmed: 33361120
Wellcome Open Res. 2020 Aug 25;5:200
pubmed: 33997297
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Biostatistics. 2016 Oct;17(4):619-33
pubmed: 26993062
Elife. 2020 May 07;9:
pubmed: 32379042
Expert Rev Mol Diagn. 2020 May;20(5):453-454
pubmed: 32297805
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
New Microbes New Infect. 2020 Nov;38:100820
pubmed: 33235799
J Infect. 2020 Nov;81(5):816-846
pubmed: 32619697
Clin Infect Dis. 2020 Nov 19;71(16):2252-2254
pubmed: 32435816
PLoS Comput Biol. 2020 Dec 10;16(12):e1008409
pubmed: 33301457
Science. 2009 May 22;324(5930):987
pubmed: 19460968
Int J Epidemiol. 2020 Oct 1;49(5):1419-1426
pubmed: 32734290
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4438-47
pubmed: 26216993
Lancet Public Health. 2020 May;5(5):e289-e296
pubmed: 32330458
Stat Med. 2009 Jun 30;28(14):1882-95
pubmed: 19387977
J Med Virol. 2013 May;85(5):924-32
pubmed: 23508918
Ecol Lett. 2017 Mar;20(3):275-292
pubmed: 28090753
PLoS One. 2015 Jul 17;10(7):e0133209
pubmed: 26186564
J Infect. 2006 Aug;53(2):106-13
pubmed: 16352342
Nature. 2018 May;557(7707):719-723
pubmed: 29795354
J Infect. 2020 Sep;81(3):357-371
pubmed: 32615199
J Infect Dis. 2015 Nov 1;212(9):1420-8
pubmed: 25883385
PLoS Comput Biol. 2020 May 4;16(5):e1007840
pubmed: 32365062
N Engl J Med. 2000 Mar 30;342(13):921-9
pubmed: 10738050
Elife. 2020 Jun 08;9:
pubmed: 32510329
Wellcome Open Res. 2020 Apr 27;5:78
pubmed: 32518842
Elife. 2021 Jul 12;10:
pubmed: 34250907
Microbes Infect. 2020 Nov - Dec;22(10):617-621
pubmed: 32911086
J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):212-4
pubmed: 15471230
PLoS Comput Biol. 2016 Jul 06;12(7):e1004901
pubmed: 27384712
Int J Antimicrob Agents. 2020 Apr;55(4):105933
pubmed: 32147516
Clin Infect Dis. 2021 May 18;72(10):e685-e686
pubmed: 32785682
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112
Lancet Infect Dis. 2020 May;20(5):515-516
pubmed: 32213336
PLoS Comput Biol. 2016 May 13;12(5):e1004882
pubmed: 27177244

Auteurs

James A Hay (JA)

Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jhay@hsph.harvard.edu lkennedyshaffer@vassar.edu mmina@hsph.harvard.edu.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Lee Kennedy-Shaffer (L)

Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jhay@hsph.harvard.edu lkennedyshaffer@vassar.edu mmina@hsph.harvard.edu.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Mathematics and Statistics, Vassar College, Poughkeepsie, NY, USA.

Sanjat Kanjilal (S)

Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Department of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.

Niall J Lennon (NJ)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Stacey B Gabriel (SB)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Marc Lipsitch (M)

Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Michael J Mina (MJ)

Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jhay@hsph.harvard.edu lkennedyshaffer@vassar.edu mmina@hsph.harvard.edu.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH